Cargando…
Multidisciplinary amyloidosis care in the era of personalized medicine
Amyloidosis refers to a group of conditions where abnormal protein—or amyloid—deposits in tissues or organs, often leading to organ malfunction. Amyloidosis affects nearly any organ system, but especially the heart, kidneys, liver, peripheral nervous system, and gastrointestinal tract. Neuromuscular...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630033/ https://www.ncbi.nlm.nih.gov/pubmed/36341129 http://dx.doi.org/10.3389/fneur.2022.935936 |
_version_ | 1784823513677299712 |
---|---|
author | Bumma, Naresh Kahwash, Rami Parikh, Samir V. Isfort, Michael Freimer, Miriam Vallakati, Ajay Redder, Elyse Campbell, Courtney M. Sharma, Nidhi Efebera, Yvonne Stino, Amro |
author_facet | Bumma, Naresh Kahwash, Rami Parikh, Samir V. Isfort, Michael Freimer, Miriam Vallakati, Ajay Redder, Elyse Campbell, Courtney M. Sharma, Nidhi Efebera, Yvonne Stino, Amro |
author_sort | Bumma, Naresh |
collection | PubMed |
description | Amyloidosis refers to a group of conditions where abnormal protein—or amyloid—deposits in tissues or organs, often leading to organ malfunction. Amyloidosis affects nearly any organ system, but especially the heart, kidneys, liver, peripheral nervous system, and gastrointestinal tract. Neuromuscular deficits comprise some of its ubiquitous manifestations. Amyloidosis can be quite challenging to diagnose given its clinical heterogeneity and multi-system nature. Early diagnosis with accurate genetic and serologic subtyping is key for effective management and prevention of organ decline. In this review, we highlight the value of a multidisciplinary comprehensive amyloidosis clinic. While such a model exists at numerous clinical and research centers across the globe, the lack of more widespread adoption of such a model remains a major hindrance to the timely diagnosis of amyloidosis. Such a multidisciplinary care model allows for the timely and effective diagnosis of amyloidosis, be it acquired amyloid light amyloidosis (AL), hereditary transthyretin amyloidosis (hATTR), or wild type amyloidosis (TTR-wt), especially in the current era of personalized genomic medicine. A multidisciplinary clinic optimizes the delivery of singular or combinatorial drug therapies, depending on amyloid type, fibril deposition location, and disease progression. Such an arrangement also helps advance research in the field. We present our experience at The Ohio State University, as one example out of many, to highlight the centrality of a multi-disciplinary clinic in amyloidosis care. |
format | Online Article Text |
id | pubmed-9630033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96300332022-11-04 Multidisciplinary amyloidosis care in the era of personalized medicine Bumma, Naresh Kahwash, Rami Parikh, Samir V. Isfort, Michael Freimer, Miriam Vallakati, Ajay Redder, Elyse Campbell, Courtney M. Sharma, Nidhi Efebera, Yvonne Stino, Amro Front Neurol Neurology Amyloidosis refers to a group of conditions where abnormal protein—or amyloid—deposits in tissues or organs, often leading to organ malfunction. Amyloidosis affects nearly any organ system, but especially the heart, kidneys, liver, peripheral nervous system, and gastrointestinal tract. Neuromuscular deficits comprise some of its ubiquitous manifestations. Amyloidosis can be quite challenging to diagnose given its clinical heterogeneity and multi-system nature. Early diagnosis with accurate genetic and serologic subtyping is key for effective management and prevention of organ decline. In this review, we highlight the value of a multidisciplinary comprehensive amyloidosis clinic. While such a model exists at numerous clinical and research centers across the globe, the lack of more widespread adoption of such a model remains a major hindrance to the timely diagnosis of amyloidosis. Such a multidisciplinary care model allows for the timely and effective diagnosis of amyloidosis, be it acquired amyloid light amyloidosis (AL), hereditary transthyretin amyloidosis (hATTR), or wild type amyloidosis (TTR-wt), especially in the current era of personalized genomic medicine. A multidisciplinary clinic optimizes the delivery of singular or combinatorial drug therapies, depending on amyloid type, fibril deposition location, and disease progression. Such an arrangement also helps advance research in the field. We present our experience at The Ohio State University, as one example out of many, to highlight the centrality of a multi-disciplinary clinic in amyloidosis care. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9630033/ /pubmed/36341129 http://dx.doi.org/10.3389/fneur.2022.935936 Text en Copyright © 2022 Bumma, Kahwash, Parikh, Isfort, Freimer, Vallakati, Redder, Campbell, Sharma, Efebera and Stino. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Bumma, Naresh Kahwash, Rami Parikh, Samir V. Isfort, Michael Freimer, Miriam Vallakati, Ajay Redder, Elyse Campbell, Courtney M. Sharma, Nidhi Efebera, Yvonne Stino, Amro Multidisciplinary amyloidosis care in the era of personalized medicine |
title | Multidisciplinary amyloidosis care in the era of personalized medicine |
title_full | Multidisciplinary amyloidosis care in the era of personalized medicine |
title_fullStr | Multidisciplinary amyloidosis care in the era of personalized medicine |
title_full_unstemmed | Multidisciplinary amyloidosis care in the era of personalized medicine |
title_short | Multidisciplinary amyloidosis care in the era of personalized medicine |
title_sort | multidisciplinary amyloidosis care in the era of personalized medicine |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630033/ https://www.ncbi.nlm.nih.gov/pubmed/36341129 http://dx.doi.org/10.3389/fneur.2022.935936 |
work_keys_str_mv | AT bummanaresh multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT kahwashrami multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT parikhsamirv multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT isfortmichael multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT freimermiriam multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT vallakatiajay multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT redderelyse multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT campbellcourtneym multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT sharmanidhi multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT efeberayvonne multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine AT stinoamro multidisciplinaryamyloidosiscareintheeraofpersonalizedmedicine |